Richard Ferrari is the Co-Founder and Managing Director of DeNovo Ventures. See sector focus and contact routes.
Richard Ferrari is the Co-Founder and Managing Director of DeNovo Ventures, a life sciences venture firm he established in 2000 with David Mauney that managed approximately $650 million across three funds before permanently closing. His investment thesis focuses exclusively on early-stage medical devices and biotechnology companies, prioritizing disruptive technologies that address unmet clinical needs in white-space areas with few competitors. The firm typically issued checks ranging from $3 million to $50 million to reflect the capital-intensive nature of medical device development, with Ferrari serving as the lead partner on 39 deals. Notable portfolio companies include Tenon Medical, where he serves as Executive Chairman, as well as HeartBeam, MedLumics, Endoshape, and Hawthorne Effect. Ferrari distinguishes his approach by advocating for a "medical device generator" funding model that secures capital up to the first-in-human stage for developed technologies, and he emphasizes that entrepreneurs must conduct fundamental clinical needs analysis before starting any project. He holds a BA in Education from Ashland University and an MBA from the Univer
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Saratoga.
Investors like Richard Ferrari · Full investor directory · Investor access · Company funding database